Plain-English translation of NCT02762162 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The Onassist Project helps cardiologists choose the best blood-thinning medications for people who have received heart stents. By analyzing your blood test results and your genetic profile for how you respond to these medications, doctors can personalize your treatment plan to reduce your risk of dangerous blood clots while minimizing bleeding complications.
After a heart stent is placed, blood-thinning medications are essential—but they don't work the same way for everyone. Some people's bodies don't respond well to standard doses, putting them at risk for clots or bleeding. This registry aims to help doctors match each patient with the medication and dose that will work best for their individual biology.
You likely qualify if…
You likely don't qualify if…
If you join, your cardiologist will share your existing blood test results and genetic profile information with the registry as part of your usual care. The study team will monitor you regularly over time to track any heart-related events or bleeding complications, helping to refine the personalized medication recommendations. There are no additional procedures or medications required—this is mainly about collecting and analyzing information you're already getting.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France
Enrollment target
~5,000 participants
Started
January 2007
Primary completion
January 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2019.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jean Philippe COLLET, MD, PhD
Action, France
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.